Company / Capital Expenditures
Structure Therapeutics Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$3.6M
FY2025
5-year range
$155.0K / $3.6M
FY2022-FY2025
Trend
+180.2%
vs FY2024
Sector context
#83 of 194
Health Care
What the data says
At $4M, Structure Therapeutics Inc.'s capital expenditures ranks #83 of 194 in the Health Care sector. Improved from $2M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of +185.7%.
Improved from $2M to $4M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +185.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 194 in Health CareTop 43% of 194This company $3.6M Sector average $117.5M
▼
-96.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +185.7%, indicating consistent growth.
- In FY2025, capital expenditures increased 180.2% year-over-year.
- Ranks #83 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | +180.2% |
| FY2024 | $1.3M | -40.5% |
| FY2023 | $2.2M | +1298.1% |
| FY2022 | $155.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026